Results for tag: "Carmoterol"

Carmoterol is a long-acting beta-2 agonist (LABA) used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing more air to flow through. Carmoterol is typically used in combination with an inhaled corticosteroid (ICS) to provide long-term control of asthma and COPD symptoms. It is available in both metered-dose inhalers (MDIs) and dry powder inhalers (DPIs). Carmoterol is one of several LABAs available on the respiratory drugs market. Other LABAs include formoterol, salmeterol, and indacaterol. These drugs are used to treat a variety of respiratory conditions, including asthma, COPD, and bronchitis. They are typically used in combination with ICSs to provide long-term control of symptoms. The companies in the Carmoterol market include GlaxoSmithKline, Merck, Novartis, and Boehringer Ingelheim. Show Less Read more